Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.
Read More…
Industry, Sector and Symbol
Industry Process control instruments
Sub-IndustryIndustrial Conglomerates
SectorMulti-Sector Conglomerates
Phone202-828-0850
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$19.89 billion
Profitability
Miscellaneous
Employees71,000
Next Earnings Date10/24/2019 (Confirmed)
OptionableOptionable
Danaher (NYSE:DHR) Frequently Asked Questions
What is Danaher's stock symbol?
Danaher trades on the New York Stock Exchange (NYSE) under the ticker symbol "DHR."
How often does Danaher pay dividends? What is the dividend yield for Danaher?
Danaher declared a quarterly dividend on Tuesday, September 10th. Shareholders of record on Friday, September 27th will be given a dividend of $0.17 per share on Friday, October 25th. This represents a $0.68 annualized dividend and a yield of 0.49%. The ex-dividend date is Thursday, September 26th. View Danaher's Dividend History.
How were Danaher's earnings last quarter?
Danaher Co. (NYSE:DHR) posted its earnings results on Thursday, October, 18th. The conglomerate reported $1.10 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.03. The conglomerate had revenue of $4.85 billion for the quarter, compared to analysts' expectations of $4.80 billion. Danaher had a return on equity of 11.53% and a net margin of 12.22%. The firm's revenue for the quarter was up 7.2% compared to the same quarter last year. During the same quarter last year, the firm posted $1.00 EPS. View Danaher's Earnings History.
When is Danaher's next earnings date?
How can I listen to Danaher's earnings call?
Danaher will be holding an earnings conference call on Thursday, October 24th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What price target have analysts set for DHR?
13 analysts have issued 12 month target prices for Danaher's stock. Their predictions range from $110.00 to $174.00. On average, they anticipate Danaher's stock price to reach $146.23 in the next twelve months. This suggests a possible upside of 5.8% from the stock's current price. View Analyst Price Targets for Danaher.
What is the consensus analysts' recommendation for Danaher?
13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Danaher in the last year. There are currently 2 hold ratings and 11 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Danaher.
Has Danaher been receiving favorable news coverage?
Media headlines about DHR stock have trended somewhat positive on Monday, InfoTrie reports. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Danaher earned a media sentiment score of 0.8 on InfoTrie's scale. They also gave news stories about the conglomerate a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Danaher.
Are investors shorting Danaher?
Danaher saw a increase in short interest in September. As of September 30th, there was short interest totalling 5,030,000 shares, an increase of 10.5% from the August 30th total of 4,550,000 shares. Based on an average daily trading volume, of 2,280,000 shares, the days-to-cover ratio is presently 2.2 days. Currently, 0.8% of the shares of the company are short sold. View Danaher's Current Options Chain.
Who are some of Danaher's key competitors?
Some companies that are related to Danaher include Roper Technologies (ROP), Fortive (FTV), Keysight Technologies (KEYS), Cognex (CGNX), Sensata Technologies (ST), MKS Instruments (MKSI), Mesa Laboratories (MLAB), Rudolph Technologies (RTEC), Hurco Companies (HURC), Crawford United (CRAWA), Hickok (HICKA), Clearsign Combustion (CLIR), Sypris Solutions (SYPR), International Isotopes (INIS) and Schmitt Industries (SMIT).
What other stocks do shareholders of Danaher own?
Who are Danaher's key executives?
Danaher's management team includes the folowing people:
- Mr. Thomas P. Joyce Jr., CEO, Pres & Director (Age 58)
- Mr. Daniel L. Comas, Exec. VP (Age 55)
- Mr. William K. Daniel II, Exec. VP (Age 54)
- Mr. Rainer M. Blair, Exec. VP (Age 55)
- Mr. Joakim Weidemanis, Exec. VP (Age 49)
Who are Danaher's major shareholders?
Danaher's stock is owned by a variety of of retail and institutional investors. Top institutional investors include CIBC Private Wealth Group LLC (0.39%), DAVENPORT & Co LLC (0.10%), Welch & Forbes LLC (0.10%), Strs Ohio (0.09%), Douglas Lane & Associates LLC (0.08%) and Envestnet Asset Management Inc. (0.07%). Company insiders that own Danaher stock include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Daniel Raskas, Donald J Ehrlich, John T Schwieters, Linda P Hefner, Matthew Mcgrew, Mitchell P Rales, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Institutional Ownership Trends for Danaher.
Which institutional investors are selling Danaher stock?
DHR stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, TIAA FSB, Zurcher Kantonalbank Zurich Cantonalbank, Gateway Investment Advisers LLC, Robecosam AG, Nisa Investment Advisors LLC, DAVENPORT & Co LLC and BTC Capital Management Inc.. Company insiders that have sold Danaher company stock in the last year include Alan G Spoon, Angela S Lalor, Brian W Ellis, Daniel L Comas, Donald J Ehrlich, Linda P Hefner, Matthew Mcgrew, Rainer Blair, Robert S Lutz, Thomas Patrick Joyce Jr, Walter G Lohr, William K Daniel and William King. View Insider Buying and Selling for Danaher.
Which institutional investors are buying Danaher stock?
DHR stock was bought by a variety of institutional investors in the last quarter, including CIBC Private Wealth Group LLC, Commerzbank Aktiengesellschaft FI, State of Alaska Department of Revenue, Envestnet Asset Management Inc., Northpointe Capital LLC, Robeco Institutional Asset Management B.V., Brinker Capital Inc. and Meeder Asset Management Inc.. View Insider Buying and Selling for Danaher.
How do I buy shares of Danaher?
Shares of DHR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Danaher's stock price today?
One share of DHR stock can currently be purchased for approximately $138.23.
How big of a company is Danaher?
Danaher has a market capitalization of $99.16 billion and generates $19.89 billion in revenue each year. The conglomerate earns $2.65 billion in net income (profit) each year or $4.52 on an earnings per share basis. Danaher employs 71,000 workers across the globe.View Additional Information About Danaher.
What is Danaher's official website?
How can I contact Danaher?
Danaher's mailing address is 2200 PENNSYLVANIA AVE. N.W SUITE 800W, WASHINGTON DC, 20037. The conglomerate can be reached via phone at 202-828-0850 or via email at [email protected]
MarketBeat Community Rating for Danaher (NYSE DHR)
MarketBeat's community ratings are surveys of what our community members think about Danaher and other stocks. Vote "Outperform" if you believe DHR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DHR will underperform the S&P 500 over the long term. You may vote once every thirty days.
